| 查看: 157 | 回复: 0 | |||
| 当前主题已经存档。 | |||
[交流]
求助：英文翻译（药学）
|
|||
|
In this , a drug is monobiotinylated in parallel with the production of a vector/avidin or a vector/strept avidin (SA) fusion protein. The biotinylated drug is produced in one vial and the vector/avid in fusion protein is produced in another vial, and the 2 vials are mixed before administration. Owing to the extremely high affinity of avid in or SA binding of biotin, there is instantaneous capture of thebiotinylatedneurotherapeutic agent by the vector/avid in or vector/SA fusion protein. Monoclonal antibody/avid in andmab/SA fusion genes and fusion proteins are produced with genetic engineering. Brain drug delivery in rats is possible with the OX26 mousemab to the rat tfr. Brain drug delivery in humans is possible with the genetically engineeredchimeric HIRmab. The activity of the genetically engineeredchimeric HIRmab is identical to that of the originalmurine HIRmab and thechimeric antibody is avidly taken up by the primate brain. The brain uptake of the HIRmab in the rhesus monkey is 2% to 4% of the injected dose which is a level of brain uptake that is 1 to 2 log orders greater than the brain uptake of aneuroactive small molecule such as morphine. |
回复此楼» 猜你喜欢
内心匮乏
已经有15人回复
-
生命口面上会评结束了吗大家有知道结果吗？现在还没有结果正常不？
已经有9人回复
-
有机物中金属离子降到1ppm以下，有什么好的方法吗？用过有机溶剂重结晶还是降不下来
已经有4人回复
-
投英文期刊如何查重
已经有6人回复
-
不要再数国自然申请书的 filecode 的分隔符个数了
已经有21人回复
-
伯胺上甲基求助
已经有7人回复
-
跨出版社商投稿
已经有5人回复
-
5个%2F，非固定段22个字母
已经有7人回复
-
生命口C13面上会评时间
已经有10人回复
-
生生命学部会评
已经有4人回复